Clinical Study
Preoperative FDG-PET/CT Is an Important Tool in the Management of Patients with Thick (T4) Melanoma
Table 5
2
2 Table of PET/CT with distant metastatic disease.
| + PET/CT with metastatic disease | Confirmed metastatic disease | | |
| Frequency percent | | | | (a) Disease present | (b) No Disease | Total | ā(a) Positive test | 5 | 3 | 8 | 7.27 | 5.45 | 12.73 | ā(b) Negative test | 0 | 48 | 48 | 0.00 | 87.27 | 87.27 | Total | 5 | 51 | 56 | 7.27 | 92.73 | 100.00 |
|
|